14 August 2024
Talking Nutrition, Health & Care
Our latest articles, covering industry news, new science, consumer insights and more.
Featured story
How to fly from concept to consumer: Unlock 9 benefits of our Premix solutions.
Our Premix solutions offering can help customers streamline their product development and launch breakthrough health solutions that address consumer needs with sustainability at the core.
Discover nine advantages of leveraging our end-to-end Premix solutions offering, from concept ideation to overcoming product development pitfalls and accelerating speed to market.
Latest Articles
-
-
5 August 2024
It takes guts and science: Unlock the latest research behind human milk oligosaccharides (HMOs) for human health
-
26 July 2024
Supercharge your odds of scientific success with the dsm-firmenich CBD API sampling program
-
26 July 2024
How to fly from concept to consumer: Unlock 9 benefits of our Premix Solutions
-
26 July 2024
Highlights from ACOG: New guidelines for omega-3 DHA + EPA supplementation and intake to reduce risk of preterm birth
-
17 July 2024
Supporting the infant microbiome: Exploring the science of synergistic synbiotics at ESPGHAN 2024
-
12 July 2024
World Brain Day 2024: 3 ‘smart’ predictions that will make you re-think the future of nootropics
-
10 July 2024
Discover the next-generation of dietary supplements solutions from dsm-firmenich and Indena
-
2 July 2024
Vitafoods Europe 2024 recap: What this year’s show told us about the nutrition industry
-
26 June 2024
How is CBtru®, a novel drug product intermediate, pioneering patient-friendly CBD-based therapies? An expert view
Latest Press Releases
-
12 September 2024
Elevating patient health: advanced taste capabilities, CBD- based formulations, and pharma expert services from dsm- firmenich at CPHI 2024
This October, dsm-firmenich, innovators in nutrition, health, and beauty, invites stakeholders across the pharmaceutical industry to immerse themselves in its patient-inspired innovations at CPHI 2024.
-
3 September 2024
dsm-firmenich Announces New Vice President of Global Commercial in Biomedical Division
The Biomedical division of dsm-firmenich is thrilled to announce the advancement of Robyn Wiseman to the role of Vice President of Global Commercial. Beginning August 26, 2024, Robyn will lead the global commercial team located throughout the Americas, EMEA, and APAC.
-
30 August 2024
dsm-firmenich secures UK and EU approvals for 3-FL and LNFP-I/2'-FL human milk oligosaccharide ingredients
dsm-firmenich, a global innovator in health, nutrition and beauty, today announced the successful approval of its human milk oligosaccharide (HMO): 3-fucosyllactose (3-FL) and lacto-N-fucopentaose I/2'-fucosyllactose (LNFP-I/2'-FL) mixture as novel food ingredients in the United Kingdom and European Union.
How can we help you?
-
New product concept
Got a notion for your next project or breakthrough innovation? Let’s put our heads together.
-
Sample request
Don’t just take our word for it. Discover how our solutions can support your product development journey.
-
-
Quick links
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
Solutions to address consumers' health and lifestyle needs, giving you an edge in the market.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.